研究单位：[1]The Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011[2]The Children's Hospital Affiliated to Suzhou University[3]Shandong Provincial Hospital[4]Guizhou Provincial People's Hospital[5]LanZhou University[6]The First Affiliated Hospital of Inner Mongolia Medical College[7]People's Hospital of Zhangjiajie[8]Puyang Oilfield General Hospital[9]The First Affiliated Hospital of Anhui Medical University[10]Guizhou Maternal and Child Health Care Hospital[11]The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University[12]Shenzhen Children's Hospital[13]The Second Affiliated Hospital of Harbin Medical University[14]Yichang Central People's Hospital[15]Xian Children's Hospital[16]Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology[17]The First People's Hospital of Yunnan[18]The First Affiliated Hospital of Xiamen University[19]The First Affiliated Hospital of Xinxiang Medical College[20]Shanxi Provincial Maternity and Children's Hospital[21]Liaocheng People's Hospital[22]Fujian Provincial Hospital[23]First Affiliated Hospital of Guangxi Medical University[24]Second Hospital of Lanzhou University[25]Guangzhou First People's Hospital[26]The Second Hospital of Shandong University[27]Children's Hospital of Hebei Province[28]Beijing Children's Hospital[29]Zhengzhou Children's Hospital[30]The Children's Hospital of Chongqing Medical University[31]Wuxi Women's & Children's Hospital[32]The Children's Hospital of Fudan University[33]Shanghai Children's Medical Center[34]Qilu Children's Hospital of Shandong University
研究目的：
This study is designed to evaluate the efficacy and safety of the current treatment option and outcome of pediatric lupus nephritis patients in China. Investigators will perform prospective registration study among at least 35 pediatric nephrology medical centers in China.
